Elvitegravir Cobicistat Emtricitabine And Tenofovir Disoprox + Valganciclovir Interaction
Moderateinteraction on record
Description
Valganciclovir is eliminated by active tubular secretion; coadministration may increase concentrations of valganciclovir and emtricitabine/tenofovir, increasing risk of adverse reactions.
Mechanism
Competition for active tubular secretion in kidneys
Source: NLP:elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate